To the Editor We read with great interest the research letter from Chauhan et al1 regarding the topic of surgical intervention in facial nonmelanoma skin cancer (fNMSC). The authors propose that age older than 90 years should be a relative contraindication for the treatment of fNMSC based on (1) the percentage of no residual carcinoma following excision (35.3% in the study) and (2) patient longevity. We agree these claims warrant further discussion; however, several points need clarification.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Hill D, Mansouri B, Housewright C. Age and Treatment of Nonmelanoma Skin Cancer. JAMA Surg. 2018;153(9):866–867. doi:10.1001/jamasurg.2018.1676
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: